256 related articles for article (PubMed ID: 10868621)
21. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
[TBL] [Abstract][Full Text] [Related]
22. Cytomegalovirus immune reconstitution occurs in recipients of allogeneic hematopoietic cell transplants irrespective of detectable cytomegalovirus infection.
Gallez-Hawkins G; Thao L; Lacey SF; Martinez J; Li X; Franck AE; Lomeli NA; Longmate J; Diamond DJ; Spielberger R; Forman SJ; Zaia JA
Biol Blood Marrow Transplant; 2005 Nov; 11(11):890-902. PubMed ID: 16275592
[TBL] [Abstract][Full Text] [Related]
23. Cytomegalovirus-specific cytolytic T-cell lines and clones generated against adenovirus-pp65-infected dendritic cells.
Keever-Taylor CA; Margolis D; Konings S; Sandford GR; Nicolette CA; Lawendowski C; Burns WH
Biol Blood Marrow Transplant; 2001; 7(5):247-56. PubMed ID: 11400946
[TBL] [Abstract][Full Text] [Related]
24. [Preparation and characterization of HLA-A * 0201 monomer and tetramer loaded with HCMV antigenic peptide].
He XH; Xu LH; Liu Y; Cai XC; Zeng YY
Sheng Wu Gong Cheng Xue Bao; 2004 May; 20(3):382-8. PubMed ID: 15971610
[TBL] [Abstract][Full Text] [Related]
25. Analysis of HLA-A24-restricted CMVpp65 peptide-specific CTL with HLA-A*2402-CMVpp65 tetramer.
Akiyama Y; Kuzushima K; Tsurumi T; Yamaguchi K
Immunol Lett; 2004 Sep; 95(2):199-205. PubMed ID: 15388261
[TBL] [Abstract][Full Text] [Related]
26. Activated virus-specific T cells are early indicators of anti-CMV immune reactions in liver transplant patients.
Benz C; Utermöhlen O; Wulf A; Villmow B; Dries V; Goeser T; Koszinowski U; Busch DH
Gastroenterology; 2002 May; 122(5):1201-15. PubMed ID: 11984506
[TBL] [Abstract][Full Text] [Related]
27. Identification of HLA-A24-restricted CTL epitope encoded by the matrix protein pp65 of human cytomegalovirus.
Akiyama Y; Maruyama K; Mochizuki T; Sasaki K; Takaue Y; Yamaguchi K
Immunol Lett; 2002 Aug; 83(1):21-30. PubMed ID: 12057851
[TBL] [Abstract][Full Text] [Related]
28. Competition of peptide-MHC class I tetrameric complexes with anti-CD3 provides evidence for specificity of peptide binding to the TCR complex.
Hoffmann TK; Donnenberg VS; Friebe-Hoffmann U; Meyer EM; Rinaldo CR; DeLeo AB; Whiteside TL; Donnenberg AD
Cytometry; 2000 Dec; 41(4):321-8. PubMed ID: 11084618
[TBL] [Abstract][Full Text] [Related]
29. Impaired killing of HCMV-infected retinal pigment epithelial cells by anti-pp65 CD8(+) cytotoxic T cells.
Allart S; Lulé J; Serres B; Jones T; Davignon JL; Malecaze F; Davrinche C
Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):665-71. PubMed ID: 12556397
[TBL] [Abstract][Full Text] [Related]
30. Identification of HLA-A33-restricted CMV pp65 epitopes as common targets for CD8(+) CMV-specific cytotoxic T lymphocytes.
Lim JB; Provenzano M; Kwon OH; Bettinotti M; Caruccio L; Nagorsen D; Stroncek D
Exp Hematol; 2006 Mar; 34(3):296-307. PubMed ID: 16543064
[TBL] [Abstract][Full Text] [Related]
31. A modified peptide stimulation method for efficient amplification of cytomegalovirus (CMV)-specific CTLs.
Ruan GP; Ma L; Wen Q; Luo W; Zhou MQ; Wang XN
Cell Mol Immunol; 2008 Jun; 5(3):197-201. PubMed ID: 18582401
[TBL] [Abstract][Full Text] [Related]
32. Induction of HLA-G-restricted human cytomegalovirus pp65 (UL83)-specific cytotoxic T lymphocytes in HLA-G transgenic mice.
Lenfant F; Pizzato N; Liang S; Davrinche C; Le Bouteiller P; Horuzsko A
J Gen Virol; 2003 Feb; 84(Pt 2):307-317. PubMed ID: 12560562
[TBL] [Abstract][Full Text] [Related]
33. High frequencies cytomegalovirus pp65(495-503)-specific CD8+ T cells in healthy young and elderly Chinese donors: characterization of their phenotypes and TCR Vbeta usage.
He XH; Zha QB; Liu Y; Xu LH; Chi XY
J Clin Immunol; 2006 Sep; 26(5):417-29. PubMed ID: 16850281
[TBL] [Abstract][Full Text] [Related]
34. Langerhans-type dendritic cells genetically modified to express full-length antigen optimally stimulate CTLs in a CD4-dependent manner.
Yuan J; Latouche JB; Hodges J; Houghton AN; Heller G; Sadelain M; Riviere I; Young JW
J Immunol; 2006 Feb; 176(4):2357-65. PubMed ID: 16455993
[TBL] [Abstract][Full Text] [Related]
35. Patients at high risk for CMV infection and disease show delayed CD8+ T-cell immune recovery after allogeneic stem cell transplantation.
Ganepola S; Gentilini C; Hilbers U; Lange T; Rieger K; Hofmann J; Maier M; Liebert UG; Niederwieser D; Engelmann E; Heilbronn R; Thiel E; Uharek L
Bone Marrow Transplant; 2007 Mar; 39(5):293-9. PubMed ID: 17262060
[TBL] [Abstract][Full Text] [Related]
36. A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects.
Berencsi K; Gyulai Z; Gönczöl E; Pincus S; Cox WI; Michelson S; Kari L; Meric C; Cadoz M; Zahradnik J; Starr S; Plotkin S
J Infect Dis; 2001 Apr; 183(8):1171-9. PubMed ID: 11262198
[TBL] [Abstract][Full Text] [Related]
37. Monitoring of cytomegalovirus-specific CD8+ T-cell response with major histocompatibility complex pentamers in kidney transplant recipients.
Lee S; Park JB; Kim EY; Joo SY; Shin EC; Kwon CH; Joh JW; Kim SJ
Transplant Proc; 2011 Sep; 43(7):2636-40. PubMed ID: 21911137
[TBL] [Abstract][Full Text] [Related]
38. Establishment of the reversible peptide-major histocompatibility complex (pMHC) class I Histamer technology: tool for visualization and selection of functionally active antigen-specific CD8(+) T lymphocytes.
Tischer S; Kaireit T; Figueiredo C; Hiller O; Maecker-Kolhoff B; Geyeregger R; Immenschuh S; Blasczyk R; Eiz-Vesper B
Int Immunol; 2012 Sep; 24(9):561-72. PubMed ID: 22740564
[TBL] [Abstract][Full Text] [Related]
39. Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.
Gratama JW; Brooimans RA; van der Holt B; Sintnicolaas K; van Doornum G; Niesters HG; Löwenberg B; Cornelissen JJ
Cytometry B Clin Cytom; 2008 Jul; 74(4):211-20. PubMed ID: 18454493
[TBL] [Abstract][Full Text] [Related]
40. The matrix protein pp65(341-350): a peptide that induces ex vivo stimulation and in vitro expansion of CMV-specific CD8+ T cells in subjects bearing either HLA-A*2402 or A*0101 allele.
Provenzano M; Lim JB; Mocellin S; Monsurro V; Bettinotti M; Marincola FM; Stroncek DF
Transfusion; 2003 Nov; 43(11):1567-74. PubMed ID: 14617317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
